Biologic classification as an alternative to anatomic staging for clinically localized prostate cancer: a proposal based on patients treated with external beam radiotherapy

By Ennis R.D.   Malyszko B.K.   Rescigno J.   Whitman A.E.   Heitjan D.F.   O'Toole K.M.   Rubin M.   Schiff P.B.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 265-270

Elsevier

Access to resources Recommend Favorite

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer

By Dillioglugil O.   Leibman B.D.   Kattan M.W.   Seale-Hawkins C.   Wheeler T.M.   Scardino P.T.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

Frequency and characterization of p53 mutations in clinically localized prostate cancer

By Hall M.C.   Navone N.M.   Troncoso P.   Pollack A.   Zagars G.K.   von Eschenbach A.C.   Conti C.J.   Chung L.W.K.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 470-475

Elsevier

Access to resources Recommend Favorite

Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer

By Lee W.R.   Schultheiss T.E.   Hanlon A.L.   Hanks G.E.  

Urology, Vol. 48, Iss. 1, 1996-07 ,pp. : 95-99

Elsevier

Access to resources Recommend Favorite

The Role of the Complexed-to-Total Prostate-Specific Antigen Ratio in Predicting the Final Pathological Stage of Clinically Localized Prostate Cancer

By Martnez M.   Navarro S.   Medina P.   Villavicencio H.   Rioja L.   Solsona E.   Estelles A.   Aznar J.   Jimenez-Cruz J.F.   Espana F.  

European Urology, Vol. 43, Iss. 6, 2003-06 ,pp. : 609-614

Elsevier

Access to resources Recommend Favorite